Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Avian Pathology : Journal of the W.V.P.A
|
June 20, 2014
Molecular typing of avian pathogenic Escherichia coli colonies originating from outbreaks of E. coli peritonitis syndrome in chicken flocks
W J M Landman, G J Buter, R Dijkman, et al.
Lancet (London, England)
|
February 29, 1992
Infection after subcutaneous interleukin-2
J Buter, E G de Vries, D T Sleijfer, et al.
Plos One
|
June 28, 2019
Molecular characterization of type 1 porcine reproductive and respiratory syndrome viruses (PRRSV) isolated in the Netherlands from 2014 to 2016
J C F M Dortmans, G J Buter, R Dijkman, et al.
Lancet (London, England)
|
March 6, 1993
Neuropsychiatric symptoms during treatment with interleukin-2
J Buter, E G de Vries, D T Sleijfer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer
J Buter, R A Janssen, A Martens, et al.
Avian Pathology : Journal of the W.V.P.A
|
September 30, 2022
Assessment of the best inoculation route for virulotyping <i>Enterococcus cecorum</i> strains in a chicken embryo lethality assay
T T M Manders, J H H van Eck, G J Buter, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Recombinant interleukin 2 for metastatic renal cell carcinoma in haemodialysis patients
J Buter, R A Janssen, N H Mulder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1992
Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis
D T Sleijfer, R A Janssen, J Buter, et al.
Blood
|
August 1, 1995
Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients
J Nieken, N H Mulder, J Buter, et al.
Journal of Hematotherapy
|
October 1, 1995
Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspects
B J Kroesen, R A Janssen, J Buter, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Avian Pathology : Journal of the W.V.P.A
|
June 20, 2014
Molecular typing of avian pathogenic Escherichia coli colonies originating from outbreaks of E. coli peritonitis syndrome in chicken flocks
W J M Landman, G J Buter, R Dijkman, et al.
Lancet (London, England)
|
February 29, 1992
Infection after subcutaneous interleukin-2
J Buter, E G de Vries, D T Sleijfer, et al.
Plos One
|
June 28, 2019
Molecular characterization of type 1 porcine reproductive and respiratory syndrome viruses (PRRSV) isolated in the Netherlands from 2014 to 2016
J C F M Dortmans, G J Buter, R Dijkman, et al.
Lancet (London, England)
|
March 6, 1993
Neuropsychiatric symptoms during treatment with interleukin-2
J Buter, E G de Vries, D T Sleijfer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer
J Buter, R A Janssen, A Martens, et al.
Avian Pathology : Journal of the W.V.P.A
|
September 30, 2022
Assessment of the best inoculation route for virulotyping <i>Enterococcus cecorum</i> strains in a chicken embryo lethality assay
T T M Manders, J H H van Eck, G J Buter, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Recombinant interleukin 2 for metastatic renal cell carcinoma in haemodialysis patients
J Buter, R A Janssen, N H Mulder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1992
Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis
D T Sleijfer, R A Janssen, J Buter, et al.
Blood
|
August 1, 1995
Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients
J Nieken, N H Mulder, J Buter, et al.
Journal of Hematotherapy
|
October 1, 1995
Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspects
B J Kroesen, R A Janssen, J Buter, et al.
Page
of 5